Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.

  title={Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.},
  author={Eric Prommer},
  journal={Cancer control : journal of the Moffitt Cancer Center},
  volume={22 4},
  • E. Prommer
  • Published 1 October 2015
  • Medicine, Psychology
  • Cancer control : journal of the Moffitt Cancer Center
BACKGROUND Advanced cancer produces multiple symptoms as patients progress through their disease trajectory. Identifying, measuring, and providing therapy for uncontrolled symptoms becomes important because disease-altering therapies may be no longer possible. Symptoms other than pain that cause distress in patients with cancer include delirium, dyspnea, anorexia, nausea, and fatigue. Precise management of these symptoms can lead to the best possible quality of life and lessen distress. This… 

Tables from this paper

Tumorassoziierte Fatigue in der Palliativsituation

Das NCCN beschreibt in der Leitlinie „Cancer-related Fatigue“ [1] häufige und für manche Patienten schwerwiegendste Beschwerde, auch in der Palliativsituation [2]. CrF beginnt meistens im Zeitraum

Management Approach for Anorexia in Palliative Care: An Integrative Literature Review

Os achados desta revisao podem colaborar para a elaboracao de protocolos para o manejo da anorexia em cuidados paliativos para maiores evidencias de eficacia.



Symptom control in advanced cancer: important drugs and routes of administration.

This article will discuss some drugs presently available to achieve good symptom control, and the list presented here is not exhaustive, but does reflect core drugs currently available in the United States.

The assessment and management of delirium in cancer patients.

The causes ofdelirium in advanced cancer, especially drug-induced delirium, and the diagnosis and management of opioid-induced neurotoxicity are outlined and management options are reviewed.

Review of Clinical Trials of Pharmacologic Interventions for Cancer-Related Fatigue: Focus on Psychostimulants and Steroids

This article reviews various pharmacological interventions for CRF, and proposes future direction for further research in methylphenidate, the most studied pharmacological agent for the treatment of CRF.

Symptom control in palliative care--Part II: cachexia/anorexia and fatigue.

Cancer cachexia tends to occur in patients with solid tumors, in children, and in elderly patients, and is associated with anorexia (loss of appetite), asthenia and changes in body image.

Palliating delirium in patients with cancer.

Cancer-related fatigue: An immense problem.

A new populationbased survey that clarifies the profound impairments associated with cancer-related fatigue is reported, and the lack of a scientific literature on fatigue deserves emphasis as one of the major barriers to improved management.

The management of dyspnea in cancer patients: a systematic review

Systemic opioids, administered orally or parenterally, can be used to manage dyspnea in cancer patients, and Nebulized morphine, prochlorperazine, and benzodiazepines are not recommended for the treatment of Dyspnea, and promethazine must not be used parentersally.

Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

There is no evidence for a beneficial effect of benzodiazepines for the relief of breathlessness in patients with advanced cancer and COPD, and a further need for well-conducted and adequately powered studies.

Treatment of Nausea and Vomiting in Terminally I11 Cancer Patients

The current approach to the palliative care of patients with nausea and vomiting is based on identifying the cause, understanding its patho-physiology and knowing the pharmacology of the drugs available for its amelioration.

ABC of palliative care: Anorexia, cachexia, and nutrition

Approaches to cachexia other than treatment of the underlying disease are covered, which may be useful to monitor nutritional changes or the effect of treatments in patients in whom body weight might be unreliable.